These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 18231723

  • 1. The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma.
    Sher DJ, Henson JW, Avutu B, Hochberg FH, Batchelor TT, Martuza RL, Barker FG, Loeffler JS, Chakravarti A.
    J Neurooncol; 2008 May; 88(1):43-50. PubMed ID: 18231723
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M.
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [Abstract] [Full Text] [Related]

  • 3. Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.
    Jalali R, Basu A, Gupta T, Munshi A, Menon H, Sarin R, Goel A.
    Br J Neurosurg; 2007 Dec; 21(6):583-7. PubMed ID: 18071985
    [Abstract] [Full Text] [Related]

  • 4. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A.
    Anticancer Res; 2003 Dec; 23(6D):5159-64. PubMed ID: 14981983
    [Abstract] [Full Text] [Related]

  • 5. Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
    Guckenberger M, Mayer M, Buttmann M, Vince GH, Sweeney RA, Flentje M.
    Strahlenther Onkol; 2011 Sep; 187(9):548-54. PubMed ID: 21858417
    [Abstract] [Full Text] [Related]

  • 6. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
    Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P.
    J Clin Oncol; 2005 Apr 01; 23(10):2372-7. PubMed ID: 15800329
    [Abstract] [Full Text] [Related]

  • 7. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.
    Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, Macdonald DR.
    J Neurooncol; 2012 Apr 01; 107(2):395-405. PubMed ID: 22105851
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
    Carlson BL, Grogan PT, Mladek AC, Schroeder MA, Kitange GJ, Decker PA, Giannini C, Wu W, Ballman KA, James CD, Sarkaria JN.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):212-9. PubMed ID: 19695438
    [Abstract] [Full Text] [Related]

  • 9. A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
    Krauze AV, Myrehaug SD, Chang MG, Holdford DJ, Smith S, Shih J, Tofilon PJ, Fine HA, Camphausen K.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):986-992. PubMed ID: 26194676
    [Abstract] [Full Text] [Related]

  • 10. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC.
    Radiat Oncol; 2015 Oct 31; 10():222. PubMed ID: 26520780
    [Abstract] [Full Text] [Related]

  • 11. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
    Gerstein J, Franz K, Steinbach JP, Seifert V, Rödel C, Weiss C.
    Strahlenther Onkol; 2011 Nov 31; 187(11):722-8. PubMed ID: 22037649
    [Abstract] [Full Text] [Related]

  • 12. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
    Skardelly M, Dangel E, Gohde J, Noell S, Behling F, Lepski G, Borchers C, Koch M, Schittenhelm J, Bisdas S, Naumann A, Paulsen F, Zips D, von Hehn U, Ritz R, Tatagiba MS, Tabatabai G.
    Oncologist; 2017 May 31; 22(5):570-575. PubMed ID: 28360216
    [Abstract] [Full Text] [Related]

  • 13. Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme.
    Roldán Urgoiti GB, Singh AD, Easaw JC.
    J Neurooncol; 2012 May 31; 108(1):173-7. PubMed ID: 22382781
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.
    Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T.
    J Clin Oncol; 2011 Jan 10; 29(2):142-8. PubMed ID: 21135282
    [Abstract] [Full Text] [Related]

  • 15. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H, Abo Hamar AH, Galal S, Zakaria F, El-Shorbagy D.
    J Egypt Natl Canc Inst; 2009 Jun 10; 21(2):107-19. PubMed ID: 21057562
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.
    Okumus NO, Gursel B, Meydan D, Ozdemir O, Odabas E, Gonullu G.
    Ann Saudi Med; 2012 Jun 10; 32(3):250-5. PubMed ID: 22588435
    [Abstract] [Full Text] [Related]

  • 17. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N, Murtha A, Pervez N, Le D, Roa W, Patel S, Mackenzie M, Fulton D, Field C, Ghosh S, Fallone G, Abdulkarim B.
    Radiat Oncol; 2013 Feb 20; 8():38. PubMed ID: 23425509
    [Abstract] [Full Text] [Related]

  • 18. Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy.
    Back MF, Ang EL, Ng WH, See SJ, Lim CC, Chan SP, Yeo TT.
    Ann Acad Med Singap; 2007 May 20; 36(5):338-42. PubMed ID: 17549280
    [Abstract] [Full Text] [Related]

  • 19. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS, Smith KA, Stea B.
    World J Surg Oncol; 2016 Aug 24; 14(1):225. PubMed ID: 27557526
    [Abstract] [Full Text] [Related]

  • 20. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.
    Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R.
    J Clin Oncol; 2006 Jun 01; 24(16):2563-9. PubMed ID: 16735709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.